Trademark: 97613188
Word
AB
Status
Pending
Status Code
730
Status Date
Wednesday, February 14, 2024
Serial Number
97613188
Mark Type
3000
Filing Date
Thursday, September 29, 2022
Published for Opposition
Tuesday, June 20, 2023

Trademark Owner History
Abdera Therapeutics Inc. - Owner At Publication

Classifications
5 chemicals for pharmaceutical use, namely, for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs used for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products used for the treatment, prevention, and diagnosis of cancer; pharmaceutical products for use in relation to radiotherapy, namely, products to target and treat tumors and cancer; pharmaceutical preparations, namely, pharmaceuticals using alpha radiation therapies for the treatment of cancer; diagnostic imaging agents for use in diagnosing cancer
44 providing medical information via a website
10 medical kits comprised of medical syringes and single and multi-dose vials of glass, sold empty, for administering pharmaceutical products used for the treatment, prevention, and diagnosis of cancer
42 medical and scientific research in the field of cancer treatment and diagnosis, in particular, radiotherapy to target and treat tumors and cancer
The mark consists of the stylized letters "AB" formed by the stylized Greek letters alpha and beta.
Color is not claimed as a feature of the mark.

Trademark Events
Feb 15, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2024
Sou Extension 1 Granted
Feb 14, 2024
Sou Extension 1 Filed
Feb 14, 2024
Sou Teas Extension Received
Aug 15, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 20, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 20, 2023
Published For Opposition
Jun 14, 2023
Assignment Of Ownership Not Updated Automatically
May 31, 2023
Notification Of Notice Of Publication E-Mailed
May 17, 2023
Approved For Pub - Principal Register
May 17, 2023
Examiner's Amendment Entered
May 17, 2023
Notification Of Examiners Amendment E-Mailed
May 17, 2023
Examiners Amendment E-Mailed
May 17, 2023
Examiners Amendment -Written
May 16, 2023
Teas/Email Correspondence Entered
May 15, 2023
Correspondence Received In Law Office
May 15, 2023
Teas Response To Office Action Received
Nov 15, 2022
Notification Of Non-Final Action E-Mailed
Nov 15, 2022
Non-Final Action E-Mailed
Nov 15, 2022
Non-Final Action Written
Nov 4, 2022
Assigned To Examiner
Oct 18, 2022
Notice Of Design Search Code E-Mailed
Oct 17, 2022
New Application Office Supplied Data Entered
Oct 3, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24